|
|
Nantes Université | |
Nantes Université is a public higher education and research institution that offers a university model that is unique in France, bringing together a university, a university hospital (CHU de Nantes), a technological research institute (IRT Jules Verne), a national research organization (Inserm) and leading schools (Centrale Nantes, École des Beaux-Arts Nantes Saint-Nazaire, École d’Architecture de Nantes). All the parties involved are focusing their efforts on developing the excellence of research in Nantes and to offering new training opportunities in all fields of knowledge. | |
Nantes Métropole | |
With its 24 municipalities, the Nantes metropolitan area has 656,275 inhabitants. More than half of the territory is made up of natural or agricultural areas and 30% of its surface area is urbanized. | |
VIDAL | |
VIDAL is a leading healthcare company providing bespoke solutions to a global healthcare market. It provides reference data and decision support solutions to communities of general practitioners, specialist doctors, pharmacists, and patients. | |
OMEDIT Pays de la Loire | |
The aim of the OMEDIT is to lead the regional health products policy defined by the Regional Health Agency (ARS) in a Multiannual Contract of Objectives and Means (CPOM). | |
PharmIA | |
PharmIA helps the hospital pharmacist to analyse the medical prescriptions and to detect and manage medication related iatrogenic risk. PharmIA identifies prescriptions to be prioritized based on potential or proven iatrogenic risk, specific dispensing constraints, or cost-related criteria. PharmIA provides clinical context to pharmacist to analyze the prescription at a glance. Pharmacists can customize controls by writing rules directly in PharmIA to trigger higly specific alerts. |
Online user: 1 | Privacy |